Seqera Labs grabs $5.5M to help sequence Covid-19 variants and other complex data problems

Seqera Labs

Seqera Labs, a Barcelona-based data orchestration and workflow platform tailored to help scientists and engineers order and gain insights from cloud-based genomic data troves, as well as to tackle other life science applications that involve harnessing complex data from multiple locations, has raised $5.5 million in seed funding

Read More

Ellipsis Health raises $26M for Behavioral Health Voice Testing

Ellipsis Health

Depression and anxiety voice test developer Ellipsis Health has closed a $26 million Series A funding round led by SJF Ventures. The startup uses voice tech and AI to measure signs of behavioral health and help screen for those who may need counseling and other care before they even visit a professional.

Read More

Israel’s DiA gets $14M to expand AI-driven ultrasound analysis

Dia analysis

Israel-based AI healthtech company, DiA Imaging Analysis, which is using deep learning and machine learning to automate analysis of ultrasound scans, has closed a $14 million Series B round of funding.

Read More

Cardiomatics bags $3.2M for its ECG-reading AI


Poland-based healthtech AI startup Cardiomatics has announced a $3.2M seed raise to expand use of its electrocardiogram (ECG) reading automation technology. The round is led by Central and Eastern European VC Kaya, with Nina Capital, Nova Capital and Innovation Nest also participating.

Read More

Accel leads Lucid Lane’s $16M round aimed at treating people with medication dependency

Lucid Lane

Telehealth company Lucid Lane raised $16 million in Series A funding to continue developing its platform that enables real-time intervention for people with medication dependence and substance-use disorders.

Read More

Mixlab raises $20M to provide purrfect pharmacy experience for pet parents


Pet pharmacy Mixlab has developed a digital platform enabling veterinarians to prescribe medications and have them delivered — sometimes on the same day — to pet parents. The New York-based company raised a $20 million Series A in a round of funding led by Sonoma Brands and including Global Founders Capital, Monogram Capital, Lakehouse Ventures and Brand Foundry. The new investment gives Mixlab total funding of $30 million, said Fred Dijols, co-founder and CEO of Mixlab.

Read More

Former Iora Health execs raise $13M to guide seniors through Medicare enrollment

Iora Health

The company’s three co-founders, Oded Eran, CEO, David Luna, chief revenue officer, and Michael Scopa, chief growth officer, saw this problem firsthand as executives at primary care company Iora Health, which is being acquired by OneMedical for $2.1 billion.

Read More

The user-experience crisis in bioinformatics & artificial intelligence softwares

Cell structure

Biology was once a domain where we could use only sight to make distinct differences between vegetal, animal & bacteria cells. During these times, it was possible for a single person to study a range variety of organisms and to still discover new mechanisms. However, nowadays you cannot simply be a biologist anymore.

Read More

Artificial Intelligence in Diagnostics market worth $3.0 billion by 2027

AI in diagnostics

The global artificial intelligence in diagnostics market size is expected to reach USD 3.0 billion by 2027, expanding at a CAGR of 32.3%, according to a new report by Grand View Research, Inc. Increase in the number of healthcare Artificial Intelligence (AI) diagnostic startups coupled with huge investments by venture capitalist firms to develop innovative technologies that allow fast and effective diagnostic procedures due to continuous increase in number of patients suffering from chronic diseases supports the growth of the market. Around 33.3% of all healthcare AI SaaS companies are engaged in developing diagnostics, making it largest focus area for startups in the market.

Read More

Caron CEO-Elect, Brad Sorte shares his insights on the impact of AI on Substance Abuse Recovery

Carron- CEO Brad Sorte

The statistics are staggering; according to American Addiction Centers, over 22 million Americans are said to struggle with substance abuse/addiction and only 10% of them are receiving treatment of any kind.  Like in so many other industries, it’s not a stretch to state that AI is revolutionizing the substance abuse  treatment sector, providing new opportunities for recognizing crisis, finding like-minded peers, early detection through genetic testing, and ultimately full recovery.

Read More

This AI startup raised $43 million to Save Lives (and Money) by treating Heart Disease earlier

Cleerly Health

This year around 650,000 Americans will die from heart disease—and many of them won’t see it coming. That’s because around 60% of people who have a heart attack don’t have any prior symptoms, says cardiologist James K. Min. Many patients don’t end up getting images of their heart and arteries until they have pain or shortness of breath, which makes diagnosis and treatment reactive instead of proactive. 

Read More

Mendel raises $18M to tease out data structure from medicine’s disparate document trove

Mendel AI

Today, a startup called Mendel, which has built an AI platform both to ingest and bring order to that body of information, is announcing $18 million in funding to continue its growth and to build out what it describes as a “clinical data marketplace” for people not just to organize, but also to share and exchange that data for research purposes. It’s also going to be using the funding to hire more talent — technical and support — for its two offices, in San Jose, CA and Cairo, Egypt.

Read More

Ada Health closes $90M Series B led by Leaps by Bayer

ada health

The digital health space continues cooking on gas: Berlin-based Ada Health has closed a $90M Series B round of funding led by Leaps by Bayer, the impact investment arm of the German multinational pharma giant, Bayer AG. Other investors in the round include Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures.

Read More

Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M


Huma, which combines data from biomarkers with predictive algorithms both to help monitor patients, and uses the same technology to help researchers and pharmaceutical companies run clinical trials, has closed an equity round of $130 million, a Series C that the company can extend to $200 million by way of a $70 million debt line if it chooses.

Read More

Elderly caretech platform Birdie gets $11.5M Series A led by Index


SaaS-maker Birdie has closed an $11.5 million Series A round of funding led by Index Ventures. Existing investor Kamet Ventures also participated. The UK-based caretech startup has raised a total of $22.9M since being founded back in 2017 (a 2018 raise that was called a Series A at the time is now being classed as a seed expansion). It’s focused on building tools for social care providers to drive efficiencies in a chronically under resourced sector.

Read More
1 2 3